Recent Drop Seen in Outpatient Care for Serious Psychological Distress
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 5, 2024 -- From 2018 to 2021, there was an increase in the rate of serious psychological distress among adults, but the rate of outpatient mental health care decreased among those with serious psychological distress, according to a study published online Feb. 5 in the Annals of Internal Medicine.
Mark Olfson, M.D., M.P.H., from Columbia University in New York City, and colleagues conducted a cross-sectional nationally representative survey of noninstitutionalized adults to characterize trends in psychological distress and outpatient mental health care. The study comprised 86,658 adults included in the Medical Expenditure Panel Survey Household Component from 2018 to 2021.
The researchers found that the rate of serious psychological distress increased from 3.5 to 4.2 percent among adults between 2018 and 2021. The rate of outpatient mental health care increased from 11.2 to 12.4 percent overall; however, among adults with serious psychological distress, there was a decrease in the rate, from 46.5 to 40.4 percent. A significant increase in outpatient mental health care was seen for younger adults (aged 18 to 44 years), but not middle-aged or older adults (aged 45 to 64 and >65 years), and for employed but not unemployed adults, after controlling for age, sex, and distress. Of mental health outpatients, 33.4 percent received at least one video visit in 2021, including a disproportionate percentage of young, college-educated, higher-income, employed, and urban adults.
"These trends underscore a public health need to broaden outpatient mental health care access to more distressed, older, and unemployed adults," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-06 22:15
Read more
- Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
- ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep
- 1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
- Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
- American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions